Abigail Raffner Basson

Dr. Abigail Raffner Basson

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2016 in Frontiers in Immunology
Verified
Journal Article
Open access
Abigail Raffner BassonAbigail Raffner Basson
Abigail Raffner Basson
ATAshley Trotter
Ashley Trotter
ARAlex Rodriguez-Palacios
Alex Rodriguez-Palacios
FCFabio Cominelli
Fabio Cominelli
Numerous reviews have discussed gut microbiota composition changes during inflammatory bowel diseases (IBD), particularly Crohn’s disease (CD). However, most studies address the observed effects by focusing on studying the univariate connection between disease and dietary-induced alterations to gut microbiota composition. The possibility that these effects may reflect a number of other interconnected (i.e. pantropic) mechanisms, activated in parallel, particularly concerning various bacterial metabolites, is in the process of been elucidated. Progress seems however hampered by various difficult-to-study factors interacting at the mucosal level. Here we highlight some of such factors that merit consideration, namely; 1) the contribution of host genetics and diet in altering gut microbiome, and in turn, the crosstalk among secondary metabolic pathways; 2) the interdependence between the amount of dietary fat, the fatty acid composition, the effects of timing and route of administration on gut microbiota community, and the impact of microbiota-derived fatty acids; 3) the effect of diet on bile acid composition, and the modulator role of bile acids on the gut microbiota; 4) the impact of endogenous and exogenous intestinal micronutrients and metabolites, and 5) the need to consider food associated toxins and chemicals which can introduce confounding immune modulating elements (e.g., antioxidant and phytochemicals in oils and proteins). These concepts, which are not mutually exclusive, are herein illustrated paying special emphasis on physiologically inter-related processes.

2 February 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
Abigail Raffner BassonAbigail Raffner Basson
Abigail Raffner Basson
CCChristy Chen
Christy Chen
FSFilip Sagl
Filip Sagl
ATAshley Trotter
Ashley Trotter
IBIlya Bederman
Ilya Bederman
ARAlexander Rodriguez-Palacios
Alexander Rodriguez-Palacios
With the epidemic of human obesity, dietary fats have increasingly become a focal point of biomedical research. Epidemiological studies indicate that high-fat diets (HFDs), especially those rich in long-chain saturated fatty acids (e.g., Western Diet, National Health Examination survey; NHANES ‘What We Eat in America’ report) have multi-organ pro-inflammatory effects. Experimental studies have confirmed some of these disease associations, and have begun to elaborate mechanisms of disease induction. However, many of the observed effects from epidemiological studies appear to be an over-simplification of the mechanistic complexity that depends on dynamic interactions between the host, the particular fatty acid, and the rather personalized genetics and variability of the gut microbiota. Of interest, experimental studies have shown that certain saturated fats (e.g., lauric and myristic fatty acid-rich coconut oil) could exert the opposite effect; that is, desirable anti-inflammatory and protective mechanisms promoting gut health by unanticipated pathways. Owing to the experimental advantages of laboratory animals for the study of mechanisms under well-controlled dietary settings, we focus this review on the current understanding of how dietary fatty acids impact intestinal biology. We center this discussion on studies from mice and rats, with validation in cell culture systems or human studies. We provide a scoping overview of the most studied diseases mechanisms associated with the induction or prevention of Inflammatory Bowel Disease in rodent models relevant to Crohn’s Disease and Ulcerative Colitis after feeding either high-fat diet (HFD) or feed containing specific fatty acid or other target dietary molecule. Finally, we provide a general outlook on areas that have been largely or scarcely studied, and assess the effects of HFDs on acute and chronic forms of intestinal inflammation.

4 April 2021 in Foods
Verified
Journal Article
Open access
PDF file
Abigail Raffner BassonAbigail Raffner Basson
Abigail Raffner Basson
SASaleh Ahmed
Saleh Ahmed
RARawan Almutairi
Rawan Almutairi
BSBrian Seo
Brian Seo
FCFabio Cominelli
Fabio Cominelli
Environmental factors, particularly diet, are considered central to the pathogenesis of the inflammatory bowel diseases (IBD), Crohn’s disease and ulcerative colitis. In particular, the Westernization of diet, characterized by high intake of animal protein, saturated fat, and refined carbohydrates, has been shown to contribute to the development and progression of IBD. During the last decade, soybean, as well as soy-derived bioactive compounds (e.g., isoflavones, phytosterols, Bowman-Birk inhibitors) have been increasingly investigated because of their anti-inflammatory properties in animal models of IBD. Herein we provide a scoping review of the most studied disease mechanisms associated with disease induction and progression in IBD rodent models after feeding of either the whole food or a bioactive present in soybean.

11 March 2021 in The Journal of Nutrition
Verified
Journal Article
Closed access
Abigail Raffner BassonAbigail Raffner Basson
Abigail Raffner Basson
AGAdrian Gomez-Nguyen
Adrian Gomez-Nguyen
ALAlexandria LaSalla
Alexandria LaSalla
LBLudovica Buttó
Ludovica Buttó
DKDanielle Kulpins
Danielle Kulpins
FCFabio Cominelli
Fabio Cominelli
The current nutritional composition of the "American diet" (AD; also known as Western diet) has been linked to the increasing incidence of chronic diseases, including inflammatory bowel disease (IBD), namely Crohn disease (CD). This study investigated which of the 3 major macronutrients (protein, fat, carbohydrates) in the AD has the greatest impact on preventing chronic inflammation in experimental IBD mouse models. We compared 5 rodent diets designed to mirror the 2011-2012 "What We Eat in America" NHANES. Each diet had 1 macronutrient dietary source replaced. The formulated diets were AD, AD-soy-pea (animal protein replaced by soy + pea protein), AD-CHO ("refined carbohydrate" by polysaccharides), AD-fat [redistribution of the ω-6:ω-3 (n-6:n-3) PUFA ratio; ∼10:1 to 1:1], and AD-mix (all 3 "healthier" macronutrients combined). In 3 separate experiments, 8-wk-old germ-free SAMP1/YitFC mice (SAMP) colonized with human gut microbiota ("hGF-SAMP") from CD or healthy donors were fed an AD, an AD-"modified," or laboratory rodent diet for 24 wk. Two subsequent dextran sodium sulfate-colitis experiments in hGF-SAMP (12-wk-old) and specific-pathogen-free (SPF) C57BL/6 (20-wk-old) mice, and a 6-wk feeding trial in 24-wk-old SPF SAMP were performed. Intestinal inflammation, gut metagenomics, and MS profiles were assessed. The AD-soy-pea diet resulted in lower histology scores [mean ± SD (56.1% ± 20.7% reduction)] in all feeding trials and IBD mouse models than did other diets (P < 0.05). Compared with the AD, the AD-soy-pea correlated with increased abundance in Lactobacillaceae and Leuconostraceae (1.5-4.7 log2 and 3.0-5.1 log2 difference, respectively), glutamine (6.5 ± 0.8 compared with 3.9 ± 0.3 ng/μg stool, P = 0.0005) and butyric acid (4:0; 3.3 ± 0.5 compared with 2.54 ± 0.4 ng/μg stool, P = 0.006) concentrations, and decreased linoleic acid (18:2n-6; 5.4 ± 0.4 compared with 8.6 ± 0.3 ng/μL plasma, P = 0.01). Replacement of animal protein in an AD by plant-based sources reduced the severity of experimental IBD in all mouse models studied, suggesting that similar, feasible adjustments to the daily human diet could help control/prevent IBD in humans.

1 December 2017 in Gastroenterology Clinics of North America
Verified
Journal Article
Closed access
Abigail Raffner BassonAbigail Raffner Basson
Abigail Raffner Basson
MLMinh Lam
Minh Lam
FCFabio Cominelli
Fabio Cominelli

23 October 2013 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
Abigail Raffner BassonAbigail Raffner Basson
Abigail Raffner Basson